# Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

> **NCT04647656** · NA · RECRUITING · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 91 (estimated)

## Conditions studied

- Covid19
- Neurocognitive Dysfunction

## Interventions

- **DEVICE:** Hyperbaric oxygen
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT04647656
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 91 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647656, "Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04647656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*